Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Joseph Thome is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/02/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/02/2024 | RAPP | Buy Now | Rapport Therapeutics | $25.16 | — | — | Initiates | → Buy | Get Alert |
| 06/18/2024 | AVTE | Buy Now | Aerovate Therapeutics | $1.65 | — | — | Downgrade | Buy → Hold | Get Alert |
| 06/17/2024 | ALKS | Buy Now | Alkermes | $24.39 | 39.4% | → $34 | Initiates | → Buy | Get Alert |
| 04/17/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $68.95 | 30.52% | $80 → $90 | Maintains | Buy | Get Alert |
| 04/08/2024 | PRME | Buy Now | Prime Medicine | $5.26 | — | — | Initiates | → Buy | Get Alert |
| 03/05/2024 | MGX | Buy Now | Metagenomi | $4.34 | — | — | Initiates | → Outperform | Get Alert |
| 03/01/2024 | PTCT | Buy Now | PTC Therapeutics | $30.18 | -0.6% | $32 → $30 | Maintains | Market Perform | Get Alert |
| 12/11/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $68.95 | 8.77% | → $75 | Initiates | → Outperform | Get Alert |
| 12/08/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $41.05 | 9.61% | → $45 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/18/2023 | EVLO | Buy Now | Evelo Biosciences | $0.00 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/24/2023 | PTCT | Buy Now | PTC Therapeutics | $30.18 | 32.54% | $47 → $40 | Maintains | Market Perform | Get Alert |
| 04/10/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $41.05 | — | — | Initiates | → Outperform | Get Alert |
| 01/05/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | $11.40 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/12/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $37.69 | — | — | Initiates | → Outperform | Get Alert |
| 12/12/2022 | ACRV | Buy Now | Acrivon Therapeutics | $5.86 | — | — | Initiates | → Outperform | Get Alert |
| 10/10/2022 | THRD | Buy Now | Third Harmonic Bio | $12.89 | — | — | Initiates | → Outperform | Get Alert |
| 06/29/2022 | AXSM | Buy Now | Axsome Therapeutics | $80.57 | 61.35% | $120 → $130 | Maintains | Outperform | Get Alert |
| 06/28/2022 | EPZM | Buy Now | Epizyme | — | — | → $1.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/31/2022 | NTLA | Buy Now | Intellia Therapeutics | $21.86 | — | — | Initiates | → Outperform | Get Alert |
| 11/23/2021 | TRDA | Buy Now | Entrada Therapeutics | $14.41 | — | — | Initiates | → Outperform | Get Alert |
